2X Blend CJC-1295 Without DAC (5mg) / Ipamorelin (5mg) PEPTIDE BLEND

Description

A 1:1 blend by mass of CJC-1295 (No DAC) and Ipamorelin supplied for controlled research environments. This co-formulation is suitable for studies exploring GHRH-receptor and ghrelin (GHS-R1a)–receptor signaling pathways when evaluated together in model systems.

Composition

• • • CJC-1295 (Without DAC): 5 mg

    • Ipamorelin: 5 mg

    • Appearance: Lyophilized powder in a sealed research vial

Research Focus (non-clinical)

2X Blend CJC-1295 Without DAC (5mg) / Ipamorelin (5mg)

• • • Comparative and combined pathway evaluation of GHRH analog + GHS agonist in in-vitro or ex-vivo models

    • Assessment of assay development, including chromatographic separation of co-formulated peptides

    • Stability characterization of a two-analyte lyophilized blend under laboratory storage conditions

Documentation

• • • COA pending — third-party verification in progress

Important Notice

• • • For research use only

    • Not for human consumption

    • Not intended to diagnose, treat, cure, or prevent any disease

Quality & Manufacturing

• • Lot-specific COA (HPLC/LC-MS) with verification key

  • Third-party verification link provided per lot (Janoshik)

  • Lyophilized for transit stability; batch traceable

  • Tamper-evident seal; lot & test date on each vial